Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE4
Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY Auto-injector
- Status
- COMPLETED
- Phase
- N/A
Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity
- Status
- TERMINATED
- Phase
- PHASE3
Pharmacokinetics of Amcenestrant in Female Hepatic Impaired Participants as Compared to Participants With Normal Hepatic Function
- Status
- TERMINATED
- Phase
- PHASE1
Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE4
Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine
- Status
- COMPLETED
- Phase
- PHASE2
Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)
- Status
- COMPLETED
- Phase
- PHASE2
Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation
- Status
- RECRUITING
- Phase
- N/A
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Mobilization of Stem Cells With AMD3100 (Plerixafor) in Combination With G-CSF in Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE4
First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and Alemtuzumab
- Status
- UNKNOWN
- Phase
- NA
A Study to Assess the Safety of Myozyme® and of Aldurazyme® in Male and Female Participants of Any Age Group With Pompe Disease or With Mucopolysaccharidosis Type I (MPS I) in a Home-care Setting
- Status
- COMPLETED
- Phase
- N/A
Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®)
- Status
- COMPLETED
- Phase
- N/A
Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy
- Status
- RECRUITING
- Phase
- PHASE2
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204)
- Status
- TERMINATED
- Phase
- PHASE2